Compare INMB & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INMB | HFBL |
|---|---|---|
| Founded | 2015 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 73.1M |
| IPO Year | 2018 | 2010 |
| Metric | INMB | HFBL |
|---|---|---|
| Price | $1.62 | $24.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 295.4K | 1.2K |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 2.49% |
| EPS Growth | 11.85 | ★ 60.32 |
| EPS | N/A | ★ 2.02 |
| Revenue | $50,000.00 | ★ $1,694,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.93 |
| Revenue Growth | ★ 257.14 | 30.01 |
| 52 Week Low | $1.09 | $14.14 |
| 52 Week High | $2.60 | $28.00 |
| Indicator | INMB | HFBL |
|---|---|---|
| Relative Strength Index (RSI) | 27.80 | 46.20 |
| Support Level | $1.36 | $21.08 |
| Resistance Level | $1.76 | $26.51 |
| Average True Range (ATR) | 0.12 | 0.44 |
| MACD | -0.03 | -0.20 |
| Stochastic Oscillator | 2.92 | 3.98 |
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Home Federal Bancorp Inc of louisiana operates as a bank holding company. Through its subsidiary, a federally chartered stock savings bank, it provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial, and multi-family segments. The company also invests in securities held-to-maturity and securities available for sale.